Cited by 274vaccines and immunoinformatics approachesResearch Data Management PracticesBiomedical Text Mining and Ontologies

The Immune Epitope Database (IEDB): 2024 update

Open access
Vita, Randi, Blazeska, Nina, Marrama, Daniel, IEDB Curation Team Members, Shackelford, Deborah, Zalman, Leora, Foos, Gabriele, Zarebski, Laura +20 more·2025·Nucleic Acids Research

Abstract

Over the past 20 years, the Immune Epitope Database (IEDB, iedb.org) has established itself as the foremost resource for immune epitope data. The IEDB catalogs published epitopes and their contextual experimental data in a freely searchable public resource. The IEDB team manually curates data from the literature into a structured format and spans infectious, allergic, autoimmune, and transplant diseases. Here, we describe the enhancements made since our 2018 paper, capturing user-directed updates to the search interface, advanced data exports, increases in data quality, and improved interoperability across related resources. As we look forward to the next 20 years, we are confident in our ability to meet the needs of our users and to contribute to the broader field of data standardization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkae1092

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 98% of all detected peptides in the immunopeptidomics assay have been previously experimentally validated and are reported in the Immune Epitope Database.

    “The specificity of the assay was corroborated by the finding that 98% of all detected peptides have been previously experimentally validated and are reported in the Immune Epitope Database [31] (Supplementary data).”

    From Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma (2025) · cites this paper as [31]

    The Introduction (page not provided) says the IEDB curates published experimental data on immune epitopes, including peptides. It does not report results from the citing paper’s immunopeptidomics assay or establish that 98% of its detected peptides were previously validated and listed in the IEDB. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vita, R., Blazeska, N., Marrama, D., IEDB Curation Team Members, Shackelford, D., Zalman, L., Foos, G., Zarebski, L., Chan, K., Reardon, B., Fitzpatrick, S., Busse, M., Coleman, S., Sedwick, C., Edwards, L., MacFarlane, C., Ennis, M., Duesing, S., Bennett, J., Greenbaum, J., De Almeida Mendes, M., Mahita, J., Wheeler, D. K., Cantrell, J. R., Overton, J. A., Natale, D. A., Sette, A., & Peters, B.
Affiliations
  • La Jolla Institute for Immunology (US)
  • Center for Vaccine Innovation, La Jolla Institute for Immunology , La Jolla , CA  92037 ,
  • Leidos (United States) (US)
  • Georgetown University Medical Center (US)
Corresponding author
Vita, Randi
Venue
Nucleic Acids Research
Published
2024-11-18
Volume
53
Issue
D1
Pages
D436-D443
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4404511368
Cited by
274
References
31
Citations by year
2026: 187 · 2025: 86 · 2024: 1
FWCI
37.30
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (75N93019C00001)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biomedical Text Mining and Ontologies
Keywords
IEDB, immune epitopes, public databases, data interoperability, data standardization, infectious diseases, autoimmune disease, allergic diseases, data export
MeSH terms
Epitopes, Humans, Software, User-Computer Interface, Databases, Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review